Apolipoprotein A-IV concentrations and clinical outcomes in a large chronic kidney disease cohort: Results from the GCKD study (2022) Schwaiger JP, Kollerits B, Steinbrenner I, Weissensteiner H, Schoenherr S, Forer L, Kotsis F, et al. Journal article Association of the metabolic syndrome with mortality and major adverse cardiac events: A large chronic kidney disease cohort (2021) Pammer LM, Lamina C, Schultheiss UT, Kotsis F, Kollerits B, Stockmann H, Lipovsek J, et al. Journal article Association of mitochondrial DNA copy number with metabolic syndrome and type 2 diabetes in 14 176 individuals (2021) Fazzini F, Lamina C, Raftopoulou A, Koller A, Fuchsberger C, Pattaro C, Del Greco FM, et al. Journal article Prevention, monitoring and treatment of cardiovascular adverse events in myeloma patients receiving carfilzomib A consensus paper by the European Myeloma Network and the Italian Society of Arterial Hypertension (2019) Bringhen S, Milan A, D'Agostino M, Ferri C, Waesch R, Gay F, Larocca A, et al. Journal article Low resting heart rates are associated with new-onset atrial fibrillation in patients with vascular disease: results of the ONTARGET/TRANSCEND studies (2015) Boehm M, Schumacher H, Linz D, Reil JC, Ukena C, Lonn E, Teo K, et al. Journal article Resting heart rate is associated with renal disease outcomes in patients with vascular disease: results of the ONTARGET and TRANSCEND studies (2015) Boehm M, Schumacher H, Schmieder R, Mann JFE, Teo K, Lonn E, Sleight P, et al. Journal article